A recent population-based cohort study, which included 1,7992 patients (8139 taking an AI and 9873 taking tamoxifen), showed a trend towards a higher risk in myocardial infarction and stroke and an increased risk of heart failure and CV mortality in the AI treated group [ 67 ].
← all excerpts
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.
1
—
—